Molly Heft-Neal

9PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 12, 2025
FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial.

Michelle Mierzwa, Benjamin Rosen, Krithika Suresh

|Sep 23, 2025
CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma.

Jiayu Wang, Megan L Ludwig, Aditi Kulkarni

|Aug 12, 2025
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn.

Dena Hasan, J Chad Brenner, Paul L Swiecicki

|Jul 14, 2025
Carcinoma ex Pleomorphic Adenoma: Multi-Institutional Retrospective Cohort Study.

Bryce Kassalow, Andrew Prince, Martin Bullock

|Jun 24, 2025
Toward a Next-Generation Liquid Biopsy for HPV+ HNSCC: Opportunities, Challenges, and the Road Ahead.

Catherine T Haring, Melina J Windon, Molly E Heft-Neal

|Mar 19, 2025
Long-Term Outcomes After Elective Contralateral Neck Dissection for HPV-Related Oropharyngeal Cancer.

Ray Y Wang, Molly E Heft Neal, Wade L Thorstad

Pageof 2

Frequent Collaborators

4 joint publications

J Chad Brenner

3 joint publications

Andrew Shuman

3 joint publications

Steven Chinn

3 joint publications

Chaz Stucken